Tokyo Tape
Sign in
← H.U. Group Holdings

Quarterly report · Q3

4544.TEDINET S100Q5GN
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥201.0bn2022-04-01 → 2022-12-31Cons.Net sales
Revenue¥272.9bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥197.9bn2021-04-01 → 2021-12-31Cons.Net sales
Operating income¥23.6bn2022-04-01 → 2022-12-31Cons.Operating income
Operating income¥36.2bn2021-04-01 → 2021-12-31Cons.Operating income
Ordinary income¥23.2bn2022-04-01 → 2022-12-31Cons.Ordinary income
Ordinary income¥47.4bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥35.5bn2021-04-01 → 2021-12-31Cons.Ordinary income
Profit before tax¥25.8bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Profit before tax¥33.7bn2021-04-01 → 2021-12-31Cons.Income before income taxes
Net income (owners)¥18.8bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥29.6bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥25.5bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent
Net income¥18.8bn2022-04-01 → 2022-12-31Cons.Profit loss
Net income¥25.5bn2021-04-01 → 2021-12-31Cons.Profit loss
Total assets¥280.3bnat 2022-12-31Cons.Assets
Total assets¥286.6bnat 2022-03-31Cons.Assets
Total assets¥277.0bnat 2021-12-31Cons.Total assets (5-year summary)
Total liabilities¥127.2bnat 2022-12-31Cons.Liabilities
Total liabilities¥146.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥153.2bnat 2022-12-31Cons.Net assets
Net assets / equity¥140.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥133.6bnat 2021-12-31Cons.Net assets (5-year summary)
Cash and deposits¥30.5bnat 2022-12-31Cons.Cash and deposits
Cash and deposits¥46.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥30.5bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥46.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥46.2bnat 2021-12-31Cons.Cash and cash equivalents
Cash & equivalents¥43.0bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥19.2bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥55.2bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥38.4bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥24.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥30.9bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥19.2bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥10.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥21.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥16.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥330.262022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥56.842022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥519.552021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥447.682021-04-01 → 2021-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥105.452021-10-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥330.222022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥519.422021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥447.552021-04-01 → 2021-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio54.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.9%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.2%at 2021-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥6.2bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥6.2bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥3.3bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥124.9bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥124.7bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥212m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥2.7bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2022-04-01 → 2022-12-31¥61.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2022-04-01 → 2022-12-31¥55.6bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥5.9bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2022-04-01 → 2022-12-31¥23.4bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2022-04-01 → 2022-12-31¥20.7bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2022-04-01 → 2022-12-31¥20.6bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥15m
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2022-04-01 → 2022-12-31¥825m
—segment totalrevenue2022-04-01 → 2022-12-31¥207.1bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥201.0bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥6.2bn
—segment totalsegment profit2022-04-01 → 2022-12-31¥26.9bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-12-31−¥7.2bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-12-31−¥7.2bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-12-31−¥775m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥131.2bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥131.0bn
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥216m
jpcrp040300-q3r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥17.7bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2021-04-01 → 2021-12-31¥52.1bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2021-04-01 → 2021-12-31¥45.2bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥7.0bn
jpcrp040300-q3r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2021-04-01 → 2021-12-31¥17.8bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2021-04-01 → 2021-12-31¥21.8bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2021-04-01 → 2021-12-31¥21.7bn
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2021-04-01 → 2021-12-31¥15m
jpcrp040300-q3r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2021-04-01 → 2021-12-31¥1.4bn
—segment totalrevenue2021-04-01 → 2021-12-31¥205.1bn
—segment totalrevenue external2021-04-01 → 2021-12-31¥197.9bn
—segment totalrevenue intersegment2021-04-01 → 2021-12-31¥7.2bn
—segment totalsegment profit2021-04-01 → 2021-12-31¥36.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 479
ItemContextValueUnit
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember－
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember260900
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember57096900
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember570969
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember114067
Number of shares issued shares voting rightsCurrentQuarterInstant57471867
Number of voting rights issued shares voting rightsCurrentQuarterInstant570969
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member260900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member260900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.0045
Number of shares held in own name treasury shares etcCurrentQuarterInstant260900
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant260900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0045
Cash and depositsPrior1YearInstant46490000000JPY
Cash and depositsCurrentQuarterInstant30481000000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant59238000000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant54406000000JPY
Merchandise and finished goodsPrior1YearInstant5148000000JPY
Merchandise and finished goodsCurrentQuarterInstant5823000000JPY
Work in processPrior1YearInstant6605000000JPY
Work in processCurrentQuarterInstant6685000000JPY
Raw materials and suppliesPrior1YearInstant7731000000JPY
Raw materials and suppliesCurrentQuarterInstant8715000000JPY
Other caPrior1YearInstant8003000000JPY
Other caCurrentQuarterInstant13074000000JPY
Allowance for doubtful accounts caPrior1YearInstant-675000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-680000000JPY
Current assetsPrior1YearInstant132542000000JPY
Current assetsCurrentQuarterInstant118507000000JPY
Buildings and structures netPrior1YearInstant21227000000JPY
Buildings and structures netCurrentQuarterInstant23787000000JPY
Tools furniture and fixtures netPrior1YearInstant14777000000JPY
Tools furniture and fixtures netCurrentQuarterInstant21765000000JPY
LandPrior1YearInstant10488000000JPY
LandCurrentQuarterInstant10560000000JPY
Other net ppePrior1YearInstant30026000000JPY
Other net ppeCurrentQuarterInstant21747000000JPY
Property plant and equipmentPrior1YearInstant76520000000JPY
Property plant and equipmentCurrentQuarterInstant77860000000JPY
GoodwillPrior1YearInstant201000000JPY
GoodwillCurrentQuarterInstant9057000000JPY
Customer related intangible assets iaPrior1YearInstant897000000JPY
Customer related intangible assets iaCurrentQuarterInstant849000000JPY
SoftwarePrior1YearInstant22250000000JPY
SoftwareCurrentQuarterInstant23487000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass